Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smartceuticals
Rome, Italysmartceuticals.it ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SmartCeuticals is an Italian biotechnology company focused on developing innovative therapeutic solutions for neurodegenerative disorders, particularly Parkinson's disease and Amyotrophic Lateral Sclerosis (ALS). The company utilizes a proprietary "Smart" delivery platform designed to enhance the bioavailability and brain penetration of established molecules, such as L-Dopa. By optimizing the pharmacokinetic profiles of these drugs, SmartCeuticals aims to reduce side effects and improve clinical outcomes for patients with chronic neurological conditions. Their research is deeply rooted in understanding autophagy and proteasome pathways in the central nervous system to address the underlying mechanisms of protein aggregation.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculeDrug delivery system
- Industry
- Biotech
Beyond the preview
Go deeper on Smartceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Smartceuticals.